SciGen Ltd. is a biopharmaceutical company which engages in the development, manufacturing and markets of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China and Others. The Singapore segment comprises of principally corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and China segment deals with sales and marketing activities. The China segment includes regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore.